Compare Nippon India Growth Mid Cap Fund vs Invesco India Mid Cap Fund
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.53 | 1.72 |
NAV | ₹4201.02 | ₹178.78 |
Fund Started | 25 Sep 1995 | 15 Feb 2007 |
Fund Size | ₹42124.50 Cr | ₹10296.36 Cr |
Exit Load | Exit load of 1% if redeemed within 1 months | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.53
1.72
NAV
₹4201.02
₹178.78
Fund Started
25 Sep 1995
15 Feb 2007
Fund Size
₹42124.50 Cr
₹10296.36 Cr
Exit Load
Exit load of 1% if redeemed within 1 months
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year | 8.12% | 10.28% |
3 Year | 24.95% | 26.47% |
5 Year | 23.34% | 22.31% |
1 Year
8.12%
10.28%
3 Year
24.95%
26.47%
5 Year
23.34%
22.31%
Equity | 97.74% | 97.50% |
Cash | 2.25% | 2.50% |
Equity
97.74%
97.50%
Cash
2.25%
2.50%
Top 10 Holdings |
|
|
Top 10 Holdings
BSE Ltd. | 3.19% |
Fortis Healthcare Ltd. | 2.84% |
The Federal Bank Ltd. | 2.60% |
AU Small Finance Bank Ltd. | 2.60% |
Persistent Systems Ltd. | 2.45% |
Cholamandalam Financial Holdings Ltd. | 2.30% |
Voltas Ltd. | 2.23% |
Ashok Leyland Ltd. | 2.21% |
Max Financial Services Ltd. | 2.02% |
Bharat Forge Ltd. | 1.90% |
The Federal Bank Ltd. | 5.79% |
AU Small Finance Bank Ltd. | 5.73% |
L&T Finance Ltd. | 5.17% |
Swiggy Ltd. | 5.14% |
Interglobe Aviation Ltd. | 4.00% |
Max Financial Services Ltd. | 3.93% |
BSE Ltd. | 3.88% |
Prestige Estates Projects Ltd. | 3.80% |
Global Health Ltd. | 3.70% |
Glenmark Pharmaceuticals Ltd. | 3.68% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme aims at long term growth of capital through research based investment approach. The funds will be invested in Equity and equity related instruments ,and there will be an exposure to debt and money market instruments also. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 25 Sep 1995 | 15 Feb 2007 |
Description
The scheme aims at long term growth of capital through research based investment approach. The funds will be invested in Equity and equity related instruments ,and there will be an exposure to debt and money market instruments also.
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
Launch Date
25 Sep 1995
15 Feb 2007